πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 401 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11077175

Compositions and methods for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11052060

Compounds and methods for treating autoimmunity

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11033601

Selective inhibition of V1b for treating fatty liver

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11013787

Sustained release formulation of interleukin-10 for wound treatment and related methods

THE REGENTS OF THE UNIVERSITY OF COLORADO FOR AND ON BEHALF OF THE UNIVERSITY OF COLORADO DENVER Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11013707

Administration of oral methyldopa

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10993834

Lacrimal system drug delivery device

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10947238

Wee1 kinase inhibitors and methods of making and using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10941392

Purification of cystathionine beta-synthase

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10940109

Multilayer polymeric matrix based medical devices

The Regents of the University of Colorado Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10913790

Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10912770

Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10912767

Anthracycline prodrugs and methods of making and using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10889625

Peptide-based methods for treating neurological injury

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10874745

Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-pola

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10857106

Methods and products for treating and/or delaying onset of dysplastic lesions

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10799567

Yeast-based immunotherapy and type I interferon sensitivity

The Regents of the University of Colorado Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10799511

Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10791731

Methods for preparing frozen plasma material for rapid thawing in an emergency situation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10760055

Conditionally immortalized long-term stem cells and methods of making and using such cells

The Regents of the University of Colorado Β· Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10751408

Compositions and methods for making and using thermostable immunogenic formulations with i

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10738123

Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10736864

Immunotherapeutic agent

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10729753

Compositions and methods for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10723784

Compositions and methods for preparing a subject for organ or non-organ implantation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted